Abstract
l-threo-3,4-Dihydroxyphenylserine (DOPS) is a chiral unnatural β-hydroxy amino acid used for the treatment of Parkinson disease. We developed a continuous bioconversion system for DOPS production that uses whole-cell biocatalyst of recombinant Escherichia coli expressing l-threonine aldolase (l-TA) genes cloned from Streptomyces avelmitilis MA-4680. Maximum conversion rates were observed at 2 M glycine, 145 mM 3,4-dihydroxybenzaldehyde, 0.75% Triton-X, 5 g E. coli cells/l, pH 6.5 and 10°C. In the optimized condition, overall productivity was 8 g/l, which represents 40 times the synthesis yield possible with no optimization of conditions.
Similar content being viewed by others
References
Baik SH, Yoshioka H, Yukawa H, Harayama S (2007) Synthesis of l-threo-3,4-dihydroxyphenylserine (l-threo-DOPS) with thermostabilized low-specific l-threonine aldolase from Streptomyces coelicolor A3(2). J Microbiol Biotechnol 17:1325–1329
Fessner WD, Helaine V (2001) Biocatalytic synthesis of hydroxylated natural products using aldolases and related enzymes. Curr Opin Biotechnol 12:574–586
Greenberg WA, Varvak A, Hanson SR, Wong K, Huang HJ, Chen P, Burk MJ (2004) Development of an efficient, scalable, aldolase-catalyzed process for enantioselective synthesis of statin intermediates. Proc Natl Acad Sci USA 101:5788–5793
Kataoka M, Ikemi M, Morikawa T, Miyoshi T, Nishi K, Wada M, Yamada H, Shimizu S (1997) Isolation and characterization of d-threonine aldolase, a pyridoxal-5′-phosphate-dependent enzyme from Arthrobacter sp. DK-38. Eur J Biochem 248:385–393
Liu JQ, Dairi T, Itoh N, Kataoka M, Shimizu S, Yamada H (1998a) Gene cloning, biochemical characterization and physiological role of a thermostable low-specificity l-threonine aldolase from Escherichia coli. Eur J Biochem 255:220–226
Liu JQ, Ito S, Dairi T, Itoh N, Shimizu S, Yamada H (1998b) Low-specific l-threonine aldolase of Pseudomonas sp. NCIMB 10558: purification, characterization and its application to β-hydroxy-α-amino acid synthesis. Appl Microbiol Biotechnol 49:702–708
Liu JQ, Odani M, Yasuoka T, Dairi T, Itoh N, Kataoka M, Shimizu S, Yamada H (2000a) Gene cloning and overexpression of low-specific d-threonine aldolase from Alcaligenes xylosoxidans and its application for production of a key intermediate for parkinsonism drug. Appl Microbiol Biotechnol 54:44–51
Liu JQ, Dairi T, Itoh N, Kataoka M, Shimizu S, Yamada H (2000b) Diversity of microbial threonine aldolases and their application. J Mol Catal B Enzym 10:107–115
Nielsen TB, Reynolds JA (1978) Measurements of molecular weights by gel electrophoresis. Methods Enzymol 48:3–10
Ohashi N, Nagata S, Ishizumi K, Maeshima K (1984) Process for producing threo-3(3,4-dihydroxyphenyl)serine. European Patent 0084928
Schmid A, Dordick JS, Hauer B, Kiener A, Wubbolts MG, Witholt B (2001) Industrial biocatalysis today and tomorrow. Nature 409:258–268
Schoemaker HE, Mink D, Wubbolts MG (2003) Dispelling the myths—biocatalysis in industrial synthesis. Science 14:1694–1697
Straathof AJ, Panke S, Schmid A (2002) The production of fine chemicals by biotransformation. Curr Opin Biotechnol 13:548–556
Tanaka F, Oda M, Fujii I (1998) Pyridoxal-mediated abzyme system for aldol and retro-aldol reactions. Tetrahedron Lett 39:5057–5060
Acknowledgements
We thank Akita Tomi for technical assistance. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) in Japan and by Chonbuk National University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baik, SH., Yoshioka, H. Enhanced synthesis of l-threo-3,4-dihydroxyphenylserine by high-density whole-cell biocatalyst of recombinant l-threonine aldolase from Streptomyces avelmitilis . Biotechnol Lett 31, 443–448 (2009). https://doi.org/10.1007/s10529-008-9885-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-008-9885-0